206 F.Supp.3d 420
D.D.C.2016Background
- GAP (public-interest NGO) FOIA-requested FDA data on 2009 sales volumes of antimicrobial drugs for food-producing animals; FDA produced two documents with redactions, dispute centers on redactions to Document 2.
- ADUFA §105 (21 U.S.C. §360b(l)(3)) requires sponsors to report annual antimicrobial sales and directs the Secretary to publish summary reports with limits (e.g., do not independently report classes with <3 sponsors; protect confidential business information).
- FDA redacted individual-sponsor data, aggregates of two sponsors, and some aggregates of ≥3 sponsors where release could enable back-calculation to smaller sponsors’ figures; FDA invoked FOIA Exemptions 3 and 4.
- GAP argued §105 is not an Exemption 3 withholding statute and that Exemption 4 (competitive harm) was not shown; AHI (industry intervenor) supported FDA on Exemption 4.
- Court held §105 is not an Exemption 3 withholding statute because its limits are tied to the Secretary’s mandated summaries and do not expressly prohibit all disclosure; Exemption 4 may apply but material factual disputes about likely substantial competitive harm preclude summary judgment.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether ADUFA §105 is an Exemption 3 withholding statute | §105 only limits content/format of the Secretary's mandatory public summaries, not all disclosures under FOIA | §105’s language and purpose bar disclosure of the withheld data generally, so it qualifies under Exemption 3 | §105 is not an Exemption 3 withholding statute; its restrictions pertain to required summary reports, not blanket FOIA nondisclosure |
| Whether the specific redactions fall within Exemption 3 even if §105 were a withholding statute | Even if §105 were a withholding statute, FDA overbroadly applied it to data beyond what §105 restricts | §105’s (E)(i)–(ii) prohibit independent reporting of small-sponsor classes and protection of confidential business information, justifying redactions | Court did not reach merits because §105 fails the threshold as a withholding statute |
| Whether redacted data constitute confidential commercial information under Exemption 4 | GAP: defendants haven’t shown disclosure would likely cause substantial competitive harm; data are stale (2009) and single-year figures are insufficient to produce reliable contemporaneous market intelligence | FDA/AHI: market is competitive; disclosure would reveal market share, enable reentry, obviate costly market research, and reveal sensitive operational/capacity info—likely causing substantial competitive injury | Exemption 4 could apply, but genuine dispute of material fact exists whether disclosure would likely cause substantial competitive harm; summary judgment denied |
| Appropriateness of summary judgment | GAP: agency burden not met on Exemption 4; §105 not an Exemption 3 statute | FDA/AHI: provided affidavits showing competition and likely harm; entitled to judgment | Summary judgment denied for all parties due to disputed material facts re: competitive injury and because Exemption 3 cannot be invoked here |
Key Cases Cited
- Pub. Citizen v. Rubber Mfrs. Ass’n, 533 F.3d 810 (D.C. Cir.) (statute with disclosure mandate not necessarily an Exemption 3 withholding statute)
- Reporters Comm. for Freedom of the Press v. U.S. Dep’t of Justice, 816 F.2d 730 (D.C. Cir.) (threshold inquiry whether statute specifically exempts matters from disclosure)
- CPSC v. GTE Sylvania, 447 U.S. 102 (Supreme Court) (distinguishable Exemption 3 holding where statute expressly prohibited release)
- John Doe #1 v. Veneman, 380 F.3d 807 (5th Cir.) (FIFRA construed as Exemption 3 withholding statute where statute expressly forbade release)
- Nat’l Parks & Conserv. Ass’n v. Morton, 498 F.2d 765 (D.C. Cir.) (Exemption 4 confidentiality tests for compelled submissions)
- Niagara Mohawk Power Corp. v. U.S. Dep’t of Energy, 169 F.3d 16 (D.C. Cir.) (Exemption 4 requires showing actual competition and likely substantial competitive injury)
- Washington Post Co. v. U.S. Dep’t of Health & Human Servs., 865 F.2d 320 (D.C. Cir.) (summary judgment inappropriate where dueling affidavits create genuine factual dispute)
- Sears, Roebuck & Co. v. Gen. Servs. Admin., 553 F.2d 1378 (D.C. Cir.) (conflicting affidavits on adverse consequences preclude summary judgment)